As research in inflammatory bowel diseases (IBD) advances, the landscape is rapidly evolving; requiring reinforcement of the most important and clinically relevant data. This educational series will provide the latest information on research, treatments, and management of IBD with a focus on the most pressing and relevant topics identified by the Crohn’s & Colitis Foundation's National Scientific Advisory Committee on Crohn’s Disease and Ulcerative Colitis.
With 1.6 million Americans living with IBD, which includes Crohn’s disease and ulcerative colitis, and approximately 70,000 new cases diagnosed annually, the Crohn’s & Colitis Foundation is dedicated to developing and cultivating IBD healthcare providers through continued education and creation of valuable resources that directly impact the standard-of-care and everyday clinical practices in IBD.
The Crohn’s & Colitis Foundation is the only national organization dedicated to driving efforts in IBD research, education and support for patients, caregivers, and professionals. The Crohn’s & Colitis Foundation is building initiatives to address high priority areas, and developing the tools, including this educational series, to educate healthcare professionals and meet patients’ needs.
In Collaboration with
Reviewing Difficult Cases in Ulcerative Colitis
Reviewing Difficult Cases in Ulcerative Colitis
Key Considerations for Managing IBD with Surgery
Key Considerations for Managing IBD with Surgery
A Perspective on Pediatric Inflammatory Bowel Disease
A Perspective on Pediatric Inflammatory Bowel Disease
A Specific Mutation in Muc2 Determines Early Dysbiosis in Colitis-Prone Winnie Mice
A Specific Mutation in Muc2 Determines Early Dysbiosis in Colitis-Prone Winnie Mice
Proactive vs. Reactive Therapeutic Drug Monitoring of Infliximab in Crohn’s Disease
Proactive vs. Reactive Therapeutic Drug Monitoring of Infliximab in Crohn’s Disease
Our Evolving Understanding of Pain in IBD
Our Evolving Understanding of Pain in IBD
2020 Crohn’s & Colitis Congress: Transitioning Pediatric IBD Patients to an Adult Practice
2020 Crohn’s & Colitis Congress: Transitioning Pediatric IBD Patients to an Adult Practice
2020 Crohn’s & Colitis Congress: Time Management Tips
2020 Crohn’s & Colitis Congress: Time Management Tips
2020 Crohn’s & Colitis Congress: Key Takeaways for APPs & RNs
2020 Crohn’s & Colitis Congress: Key Takeaways for APPs & RNs
2020 Crohn’s & Colitis Congress: Research Takeaways
2020 Crohn’s & Colitis Congress: Research Takeaways
2020 Crohn’s & Colitis Congress: Pain, Fatigue, & Nutrition in IBD
2020 Crohn’s & Colitis Congress: Pain, Fatigue, & Nutrition in IBD
2020 Crohn’s & Colitis Congress: IBD Care Outside the Gut
2020 Crohn’s & Colitis Congress: IBD Care Outside the Gut
2020 Crohn’s & Colitis Congress: Guidance on Caring for Young Patients
2020 Crohn’s & Colitis Congress: Guidance on Caring for Young Patients
2020 Crohn’s & Colitis Congress: Explaining Risk to Patients
2020 Crohn’s & Colitis Congress: Explaining Risk to Patients
2020 Crohn’s & Colitis Congress: How & When to Perform Disease & Drug Monitoring
2020 Crohn’s & Colitis Congress: How & When to Perform Disease & Drug Monitoring
